Graph AI raises $3M to advance its AI-driven pharmacovigilance platform

Graph AI secured $3M seed funding led by Bessemer Venture Partners for its AI-driven pharmacovigilance platform, Graph Safety. Founded by Raghav Parvataraju, Vijay Ponukumati, Mohan Konyala, and Ashutosh Bordekar, it automates adverse drug event monitoring and regulatory submissions. Targeting the $8B pharmacovigilance market, Graph AI achieves 70% efficiency gains and 90% faster reporting. The investment reflects growing AI adoption in healthtech, demonstrating investor confidence in AI’s healthcare transformation potential.